Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michael Saccente

Concepts (110)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Histoplasmosis
2
2021
48
0.850
Why?
Acquired Immunodeficiency Syndrome
3
2021
53
0.730
Why?
Lymphogranuloma Venereum
1
2022
2
0.710
Why?
Proctocolitis
1
2022
2
0.710
Why?
Pneumonia, Pneumocystis
1
2021
6
0.700
Why?
Pneumocystis carinii
1
2021
4
0.700
Why?
beta-Glucans
1
2021
23
0.690
Why?
Sweet Syndrome
1
2021
11
0.660
Why?
Mycobacterium Infections, Nontuberculous
1
2021
19
0.650
Why?
Inflammatory Bowel Diseases
1
2022
89
0.640
Why?
Antifungal Agents
4
2008
350
0.610
Why?
Citrus paradisi
2
2008
10
0.480
Why?
Food-Drug Interactions
2
2008
14
0.480
Why?
Itraconazole
2
2008
37
0.470
Why?
HIV Infections
3
2006
402
0.420
Why?
Blastomyces
1
2010
17
0.310
Why?
Blastomycosis
1
2010
33
0.310
Why?
Beverages
2
2008
58
0.270
Why?
Candida
1
2008
63
0.260
Why?
Arthritis, Infectious
1
2008
45
0.260
Why?
Candidiasis
1
2008
114
0.250
Why?
Anti-Retroviral Agents
1
2006
18
0.250
Why?
Mycobacterium fortuitum
1
2006
6
0.240
Why?
Joint Diseases
1
2006
40
0.230
Why?
Tuberculosis
2
2009
133
0.230
Why?
Patient Compliance
1
2006
232
0.220
Why?
Prosthesis-Related Infections
1
2006
109
0.210
Why?
beta-Cyclodextrins
1
2004
15
0.210
Why?
Humans
18
2022
53246
0.200
Why?
Amphotericin B
1
2003
105
0.190
Why?
Male
11
2022
27444
0.180
Why?
Glucans
1
2021
10
0.170
Why?
Tuberculin Test
1
2001
8
0.170
Why?
Homosexuality, Male
1
2022
54
0.170
Why?
Adult
9
2021
14541
0.170
Why?
Infectious Disease Transmission, Vertical
1
2000
18
0.160
Why?
Autoantibodies
1
2021
120
0.160
Why?
Interferon-gamma
1
2021
174
0.160
Why?
Cat-Scratch Disease
1
1999
7
0.150
Why?
Liver Abscess
1
1999
5
0.150
Why?
Retinitis
1
1999
5
0.150
Why?
Meningitis
1
1999
25
0.150
Why?
Klebsiella Infections
1
1999
13
0.150
Why?
Optic Neuritis
1
1999
21
0.150
Why?
Klebsiella pneumoniae
1
1999
21
0.150
Why?
Facial Paralysis
1
1999
25
0.150
Why?
Vancomycin Resistance
1
2019
6
0.150
Why?
Endophthalmitis
1
1999
25
0.150
Why?
Chronic Disease
1
2022
581
0.150
Why?
Diabetes Complications
1
1999
124
0.140
Why?
Vancomycin
1
2019
91
0.140
Why?
Staphylococcal Infections
1
2019
271
0.120
Why?
Pharmaceutical Solutions
2
2008
9
0.120
Why?
Macrophages
1
2019
380
0.120
Why?
Staphylococcus aureus
1
2019
313
0.120
Why?
Area Under Curve
2
2008
185
0.120
Why?
Cross-Over Studies
2
2008
241
0.110
Why?
Anti-Bacterial Agents
1
2019
832
0.100
Why?
Female
8
2010
28792
0.090
Why?
Arthroplasty, Replacement, Knee
2
2006
289
0.080
Why?
Ixodes
1
2010
6
0.080
Why?
Borrelia burgdorferi
1
2010
31
0.080
Why?
Lyme Disease
1
2010
32
0.080
Why?
Retrospective Studies
1
2021
6821
0.070
Why?
Pancreatic Diseases
1
2009
17
0.070
Why?
AIDS-Related Opportunistic Infections
1
2009
38
0.070
Why?
Drug Resistance, Fungal
1
2008
35
0.070
Why?
Cytochrome P-450 CYP3A
1
2008
78
0.060
Why?
Administration, Oral
1
2008
456
0.060
Why?
Sex Factors
1
2008
747
0.060
Why?
Cyclodextrins
1
2004
16
0.050
Why?
Critical Illness
1
2006
316
0.050
Why?
Biological Availability
1
2004
107
0.050
Why?
Middle Aged
4
2009
13422
0.050
Why?
Burkholderia
1
2002
9
0.050
Why?
Ultrasonics
1
2002
26
0.050
Why?
Staphylococcus
1
2002
31
0.050
Why?
Fatal Outcome
1
2003
193
0.050
Why?
Knee Prosthesis
1
2002
52
0.040
Why?
Hip Prosthesis
1
2002
73
0.040
Why?
Biofilms
1
2002
184
0.040
Why?
Scotoma
1
1999
6
0.040
Why?
Arkansas
2
2010
2068
0.040
Why?
Fundus Oculi
1
1999
26
0.040
Why?
Visual Field Tests
1
1999
16
0.040
Why?
Lysostaphin
1
2019
2
0.040
Why?
Multilocus Sequence Typing
1
2019
7
0.040
Why?
Aged
3
2019
10430
0.040
Why?
Daptomycin
1
2019
29
0.040
Why?
Cell Wall
1
2019
59
0.040
Why?
Prenatal Care
1
2000
111
0.040
Why?
Arthroplasty, Replacement, Hip
1
2002
268
0.040
Why?
Bacteremia
1
2019
87
0.030
Why?
Microbial Sensitivity Tests
1
2019
276
0.030
Why?
Mass Screening
1
2000
362
0.030
Why?
Incidence
1
2000
1085
0.030
Why?
Mutation
1
2019
1338
0.020
Why?
Pregnancy
1
2000
2610
0.020
Why?
Infant, Newborn
1
2000
2913
0.020
Why?
Risk Factors
1
2000
4018
0.020
Why?
Antiretroviral Therapy, Highly Active
1
2009
32
0.020
Why?
HIV-1
1
2009
60
0.020
Why?
Adolescent
1
2000
6912
0.020
Why?
Antitubercular Agents
1
2009
89
0.020
Why?
Mycobacterium tuberculosis
1
2009
250
0.020
Why?
Filtration
1
2002
19
0.010
Why?
Colony Count, Microbial
1
2002
59
0.010
Why?
Prospective Studies
1
2002
2412
0.010
Why?
Aged, 80 and over
1
2002
3495
0.010
Why?
Animals
1
2010
13528
0.010
Why?
Saccente's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description